Theraclion Stock OTC Markets
Stocks
TCLIF
FR0010120402
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
04:47:35 09/04/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.5320 USD | +66.25% |
|
-.--% | +66.25% |
| 17/09 | Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 17/09 | Theraclion widens its operating loss in the first half |  |
| Market Cap | 49.71M 55.97M 46.49M 42.37M 79.76M 5.39B 80.86M 562M 218M 2.74B 210M 206M 8.82B | P/E 2024 |
-2.66x | P/E 2025 | -6.33x |
|---|---|---|---|---|---|
| Enterprise Value | 57.57M 64.81M 53.83M 49.06M 92.36M 6.24B 93.63M 651M 252M 3.18B 243M 238M 10.21B | EV / Sales 2024 |
22.5x | EV / Sales 2025 | 55.4x |
| Free-Float |
32.52% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +66.25% | ||
| 6 months | +66.25% | ||
| Current year | +66.25% |
| Current year | 0.53 |  | 0.53 |
| 1 year | 0.53 | | 0.53 |
| 3 years | 0 | | 0.53 |
| 5 years | 0 | | 0.59 |
| 10 years | 0 | | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Deterre
CEO | Chief Executive Officer | - | 24/05/2023 |
Julie Veisseire
DFI | Director of Finance/CFO | - | - |
Alexandra Rocher
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Mehdi El Glaoui
BRD | Director/Board Member | - | 22/06/2021 |
Cédric Bellanger
BRD | Director/Board Member | - | 28/01/2022 |
Lijuan Deng
BRD | Director/Board Member | - | 29/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +66.25% | -.--% | - | - | 55.97M | |
| -3.34% | -3.81% | +22.95% | +28.91% | 241B | |
| -4.42% | -5.37% | -0.53% | -14.65% | 149B | |
| -1.33% | +0.43% | -8.40% | +37.27% | 142B | |
| -0.96% | -3.25% | -54.90% | -18.12% | 62.65B | |
| -1.31% | -0.63% | +11.64% | +22.96% | 49.1B | |
| -3.27% | -3.56% | +20.28% | +49.06% | 46.99B | |
| +0.76% | +0.56% | -18.99% | -20.95% | 47.13B | |
| -1.23% | +2.58% | -3.86% | +38.57% | 45.65B | |
| -3.15% | -1.11% | +33.06% | +55.18% | 41.81B | |
| Average | +4.80% | +0.29% | +0.14% | +19.81% | 91.69B | |
| Weighted average by Cap. | -2.52% | +0.45% | +3.23% | +18.73% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 830K 935K 776K 708K 1.33M 89.99M 1.35M 9.39M 3.64M 45.83M 3.51M 3.43M 147M | 652K 734K 610K 556K 1.05M 70.68M 1.06M 7.38M 2.86M 35.99M 2.76M 2.7M 116M |
| Net income | -5.76M -6.48M -5.38M -4.91M -9.24M -624M -9.36M -65.13M -25.21M -318M -24.34M -23.81M -1.02B | -5.69M -6.41M -5.32M -4.85M -9.13M -617M -9.25M -64.37M -24.92M -314M -24.05M -23.53M -1.01B |
| Net Debt | 3.41M 3.84M 3.19M 2.91M 5.47M 370M 5.55M 38.59M 14.94M 188M 14.42M 14.1M 605M | 7.85M 8.84M 7.34M 6.69M 12.6M 851M 12.77M 88.83M 34.39M 433M 33.19M 32.47M 1.39B |
Employees
36
Calendar
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHE Stock
- TCLIF Stock
Select your edition
All financial news and data tailored to specific country editions
